Gogoro Inc vs Philip Morris International Inc. — how do they compare? Gogoro Inc trades at $3.86 (market cap $77.38M), while Philip Morris International Inc. trades at $186.9 (market cap $281.91B). The key difference: Philip Morris International Inc. is far larger — about 3643.2× Gogoro Inc's market cap, and Philip Morris International Inc. pays a 3.25% dividend while Gogoro Inc pays none. Which is the better fit depends on your goals.
| GGR | PM | |
|---|---|---|
Market Cap | $77.38M | $281.91B |
Sector | Technology | Consumer Staples |
52-Week High | $7.89 | $191.86 |
52-Week Low | $2.74 | $144.33 |
Enterprise Value | $379.83M | $328.41B |
Dividend Yield | — | 3.25% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Philip Morris International (PM) trades at $175.95, down 2.35% amid a bearish technical signal and recent profit forecast revision. The company reported strong Q1 2026 EPS of $1.96, beating estimates, but faces headwinds from a $500 million impairment charge and margin pressures. Revenue growth remains steady, with 2025 revenue at $40.65 billion and net income margin of 26.74%. Analyst consensus is bullish with a $194 price target, though technical indicators show resistance near $179.
The stock presents a mixed outlook: solid fundamentals and high analyst buy ratings support upside potential, but near-term risks include cost pressures, currency volatility, and illicit market growth. Long-term investors may find value in the dividend and brand strength, while caution is warranted due to regulatory and macroeconomic challenges.
Trailing returns across standard periods
Gogoro is a global technology leader in battery-swapping ecosystems for electric two-wheelers. It provides smart, sustainable urban mobility solutions and manages an extensive network of battery stations.
Read more on GGR →Philip Morris International is an international tobacco company with a product portfolio primarily consisting of cigarettes and reduced-risk products, including heat-not-burn, vapor and oral nicotine products, which are sold in markets outside the United States. The company diversified away from nicotine products with the acquisition of Vectura, a provider of innovative inhaled drug delivery solutions, in 2021.
Read more on PM →